UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 210

Sortiert nach

Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development

Cancer prevention research (Philadelphia, Pa.), 2018-07, Vol.11 (7), p.371-382

2018

Link zum Volltext

Verfügbarkeit prüfen

Sp transcription factor family and its role in cancer

European journal of cancer (1990), 2005-11, Vol.41 (16), p.2438-2448

2005

Link zum Volltext

Verfügbarkeit prüfen

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies

Biomedicines, 2021-04, Vol.9 (4), p.389

2021

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer

The Journal of biological chemistry, 2014-10, Vol.289 (40), p.27692-27701

2014

Link zum Volltext

Verfügbarkeit prüfen

Newest Therapies for Cholangiocarcinoma: An Updated Overview of Approved Treatments with Transplant Oncology Vision

Cancers, 2022-10, Vol.14 (20), p.5074

2022

Link zum Volltext

Verfügbarkeit prüfen

Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature

Journal for immunotherapy of cancer, 2019-04, Vol.7 (1), p.106-106, Article 106

2019

Link zum Volltext

Verfügbarkeit prüfen

Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer

Cancers, 2022-11, Vol.14 (22), p.5615

2022

Link zum Volltext

Verfügbarkeit prüfen

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

Journal for immunotherapy of cancer, 2019-01, Vol.7 (1), p.2-13, Article 2

2019

Link zum Volltext

Verfügbarkeit prüfen

Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review

Frontiers in pharmacology, 2021-12, Vol.12

2021

Link zum Volltext

Verfügbarkeit prüfen

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma

Cancers, 2022-05, Vol.14 (11), p.2641

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report

Current oncology (Toronto), 2022-06, Vol.29 (6), p.4267-4273

2022

Link zum Volltext

Verfügbarkeit prüfen

Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma

PloS one, 2015-06, Vol.10 (6), p.e0128308-e0128308

2015

Link zum Volltext

Verfügbarkeit prüfen

Cyclooxygenase-2 Inhibitors Decrease Vascular Endothelial Growth Factor Expression in Colon Cancer Cells by Enhanced Degradation of Sp1 and Sp4 Proteins

Molecular pharmacology, 2005-08, Vol.68 (2), p.317-329

2005

Link zum Volltext

Verfügbarkeit prüfen

Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

Oncoimmunology, 2021-01, Vol.10 (1), p.1927313-1927313

2021

Link zum Volltext

Verfügbarkeit prüfen

725 Immunomodulation by targeting PDL-1 in colon cancer using nuclear receptor 4A1 (NR4A1) antagonists

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A754-A755

2021

Link zum Volltext

Verfügbarkeit prüfen

3,3′-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5

Carcinogenesis (New York), 2006-04, Vol.27 (4), p.717-728

2006

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening

Current oncology (Toronto), 2022-11, Vol.29 (11), p.8693-8719

2022

Link zum Volltext

Verfügbarkeit prüfen

Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View

Cancers, 2022-03, Vol.14 (7), p.1760

2022

Link zum Volltext

Verfügbarkeit prüfen

Transplant Oncology: An Evolving Field in Cancer Care

Cancers, 2021-09, Vol.13 (19), p.4911

2021

Link zum Volltext

Verfügbarkeit prüfen

Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis

Oncoimmunology, 2021-01, Vol.10 (1), p.1877415-1877415

2021

Link zum Volltext

Verfügbarkeit prüfen

Tolfenamic Acid and Pancreatic Cancer Growth, Angiogenesis, and Sp Protein Degradation

JNCI : Journal of the National Cancer Institute, 2006-06, Vol.98 (12), p.855-868

2006

Link zum Volltext

Verfügbarkeit prüfen

Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate Decreases Specificity Protein Transcription Factors and Inhibits Pancreatic Tumor Growth: Role of MicroRNA-27a

Molecular pharmacology, 2010-08, Vol.78 (2), p.226-236

2010

Link zum Volltext

Verfügbarkeit prüfen

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer

Frontiers in oncology, 2022-12, Vol.12, p.992455

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer

Cancer chemotherapy and pharmacology, 2020-03, Vol.85 (3), p.621-626

2020

Link zum Volltext

Verfügbarkeit prüfen

Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience

Cancers, 2022-01, Vol.14 (3), p.650

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(186)
Mit Volltextzugriff
(194)

Publikationsform

Sprache

Englisch
(210)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(26)
Cancer Research
(20)
Journal For Immunotherapy Of Cancer
(11)
Molecular Cancer Therapeutics
(11)
Cancers
(10)
The Journal Of Biological Chemistry
(7)
Endocrinology
(6)
Molecular Pharmacology
(6)
Brachytherapy
(4)
Carcinogenesis
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development

Sp transcription factor family and its role in cancer

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies

Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer

Newest Therapies for Cholangiocarcinoma: An Updated Overview of Approved Treatments with Transplant Oncology Vision

Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature

Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma

Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report

Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma

Cyclooxygenase-2 Inhibitors Decrease Vascular Endothelial Growth Factor Expression in Colon Cancer Cells by Enhanced Degradation of Sp1 and Sp4 Proteins

Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

725 Immunomodulation by targeting PDL-1 in colon cancer using nuclear receptor 4A1 (NR4A1) antagonists

3,3′-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5

Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening

Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View

Transplant Oncology: An Evolving Field in Cancer Care

Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis

Tolfenamic Acid and Pancreatic Cancer Growth, Angiogenesis, and Sp Protein Degradation

Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate Decreases Specificity Protein Transcription Factors and Inhibits Pancreatic Tumor Growth: Role of MicroRNA-27a

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer

Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer

Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience

Suchergebnisse filtern